SANJAY MISRA

Sanjay Misra provides specialized consulting services in medical device development, with a focus on neurosurgical innovation and regulatory strategy under the Blueprint MedTech Initiative. As a subject matter expert in neurosurgery, the contractor delivers high-level technical guidance to accelerate the design, testing, and regulatory pathway for next-generation neurostimulation and implantable devices. Their work integrates clinical insight with FDA compliance frameworks, ensuring alignment with 21 CFR Part 820, ISO 13485, and premarket submission requirements. Differentiators include deep domain expertise in neuroanatomy, intraoperative monitoring systems, and human factors engineering for neurotech applications, enabling clients to navigate complex clinical validation and risk management processes with precision. The contractor has demonstrated direct engagement with the Department of Health and Human Services, supporting initiatives aimed at advancing transformative medical technologies through expert advisory roles. This relationship reflects a targeted, mission-driven engagement focused on accelerating innovation in neurological care, particularly within HHS’s research and development arms such as the National Institutes of Health or the Center for Devices and Radiological Health. The primary NAICS classification of 541990 reflects a niche position in professional scientific consulting, specifically applied to biomedical engineering and regulatory science. The contractor’s market positioning centers on bridging clinical neurosurgical practice with federal procurement of advanced medical devices, serving as a trusted advisor to agencies investing in next-generation neurotechnologies. Sanjay Misra operates as a sole proprietorship (Entity Structure 2J) based in Frisco, CO, with no public certifications on record. The business model emphasizes individualized, high-impact expertise rather than institutional scale, positioning the contractor as a specialized resource for federal agencies requiring authoritative clinical and technical guidance in neurotechnology development. Geographic presence is limited to a single location, with service delivery occurring primarily through remote advisory and federal contract performance.